Nplate®

Active substance

Holder

Status

closed

Indication

Treatment of adult patients with Primary Immune thrombocytopenia (ITP) within the first 12 months of diagnosis who are refractory to other treatments (e.g. corticosteroids, immunoglobulins)

Public documents

Approbation

Information for the patient

Informed consent

Last update

11/08/2022